Envista Corp (NVST)
NYSE: NVST
· Real-Time Price · USD
16.38
-0.59 (-3.48%)
At close: May 06, 2025, 3:59 PM
16.39
0.09%
After-hours: May 06, 2025, 04:20 PM EDT
-3.48% (1D)
Bid | 15 |
Market Cap | 2.78B |
Revenue (ttm) | 2.5B |
Net Income (ttm) | -1.12B |
EPS (ttm) | -6.14 |
PE Ratio (ttm) | -2.67 |
Forward PE | 14.62 |
Analyst | Hold |
Ask | 17.36 |
Volume | 1,865,880 |
Avg. Volume (20D) | 3,066,185 |
Open | 16.62 |
Previous Close | 16.97 |
Day's Range | 16.32 - 16.77 |
52-Week Range | 14.22 - 23.00 |
Beta | 1.12 |
About NVST
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Cons...
Industry Medical - Equipment & Services
Sector Healthcare
IPO Date Sep 18, 2019
Employees 12,300
Stock Exchange NYSE
Ticker Symbol NVST
Website http://www.envistaco.com/
Analyst Forecast
According to 13 analyst ratings, the average rating for NVST stock is "Hold." The 12-month stock price forecast is $21, which is an increase of 28.24% from the latest price.
Stock ForecastsEarnings Surprise
Envista Corp has released their quartely earnings
on May 1, 2025:
2 months ago
+5.93%
Envista Holdings shares are trading higher after t...
Unlock content with
Pro Subscription
6 months ago
+9.05%
Envista Holdings shares are trading higher after Leerink Partners upgraded the stock from Underperform to Market Perform and raised its price target from $16 to $23. Additionally, Baird raised its price target on the stock from $17 to $22.